Stem Cell Research Enhancement Act of 2005

H.R. 810, the Stem Cell Research Enhancement Act of 2005, sought to expand federal funding for research involving human embryonic stem cells. Under the policy at the time, federal funding was restricted to a limited number of stem cell lines created before August 2001; this bill would have allowed the government to support research on newer lines, provided the embryos were originally created for fertility treatments, were no longer needed, and were donated voluntarily without financial compensation.

For citizens, the bill aimed to accelerate medical research into potential treatments for chronic diseases and injuries, such as Parkinson’s, diabetes, and spinal cord damage, by giving scientists access to a wider array of research materials. Although the bill passed both the House and the Senate with bipartisan support, it was ultimately vetoed by the President and did not become law.